Elizabeth Holmes Documentary ‘You Can See Everything’ Reportedly Debuts With $15M Opening

A new documentary about disgraced Theranos founder Elizabeth Holmes, You Can See Everything, reportedly debuted with a $15 million opening weekend, initial reports claim. But big-box office tracking firms and the film’s official theatrical distributors have yet to confirm the numbers.

Meanwhile, a documentary about Elizabeth Holmes, “You Can See Everything,” is reportedly set to make $15 million on its opening weekend. But the film’s release and these financial numbers are not yet confirmed by official box office data from tracking firms like Comscore, so they remain unverified by primary industry sources.

According to those early reports on the film You Can See Everything, the documentary about the rise and fall of Theranos and its founder Elizabeth Holmes, had a huge $15 million opening weekend. If true, it would be a remarkable financial accomplishment for a non-fiction film.

But again, as with normal journalistic and industry verification, we need confirmation from primary box office tracking entities such as Comscore or official press releases from the film’s distributing studio. At the time of this report, neither of these official channels has released data confirming the $15 million gross or the number of theaters where You Can See Everything is currently playing.

The $15 million debut weekend is a figure normally reserved for wide-release narrative features from major studios in today’s film business. Few documentaries hit that mark in their opening frames, unless they’re massive concert films or unprecedented cultural phenomena. So the reported You Can See Everything number must be independently verified before it can be described as a bona fide industry record.

Representatives for the alleged distributors, production companies, and major box office tracking firms have not yet issued official statements, press releases, or data confirming the $15 million figure.

The $15 million opening weekend is unverified until recognized industry trackers release official theatrical exhibition data.

The public’s ongoing fascination with Elizabeth Holmes and the Theranos scandal has created a large media footprint in the last several years. Holmes founded Theranos, a health technology company that claimed it could revolutionize blood testing. The company eventually collapsed after investigations revealed its main technology was fraudulent and that it had misled investors, doctors, and patients.

In January 2022, Holmes was found guilty of four counts of defrauding investors. She was jailed for more than 11 years and started her sentence in May 2023.

You Can See Everything is the most widely recognized documentary about the scandal, before Alex Gibney’s The Inventor: Out for Blood in Silicon Valley. The film premiered at the Sundance Film Festival in 2019 and was released on HBO, skipping a wide theatrical release. The scandal was also adapted into a dramatized limited series, The Dropout, starring Amanda Seyfried as Holmes. The series premiered on Hulu in 2022 and won several Emmy Awards.

The reported theatrical release of Everything marks a shift in how audiences receive the Theranos story, from premium cable and streaming dramatizations to a reported wide-release documentary format.

If the reported $15 million opening weekend for You Can See Everything is accurate, it would signal a seismic shift in the theatrical viability of true-crime and corporate-fraud documentaries. It would also highlight the continuing public fascination with the Theranos scandal, more than a decade since the company was first exposed and years after Holmes was convicted.

However, if the numbers are the result of poor reporting, inflated by hype or the one-off showing of a film being reported as a wide release, it reinforces the need to turn to trusted industry trackers for financial film information.

Industry trackers expect to wrap up and release official weekend box office numbers later this week. Once the data is verified, we’ll know the film’s actual theater count, per-screen averages, and the official distributing studio.

Also, if the movie does well at the box office, expect announcements about follow-up streaming rights and digital VOD release windows.